Articles that mention Alexion Pharmaceuticals -BoardProspects

Alexion Pharmaceuticals

0 Comments Leave a Comment

1-10 of 10
1. Mentioned In 10 Articles
2. Xilio Therapeutics Appoints Paul J. Clancy to its Board of Directors
  
  Explore businesswire.com Jul 23 2020 BoardMoves
  
  ...armaceuticals and Incyte Corporation. Mr. Clancy was Executive Vice President and Chief Financial Officer for Alexion Pharmaceuticals from July 2017 to October 2019. Prior to that, Mr. Clancy was Executive Vice President...
  Read Full Article
  
  Comment
  
  Mentions: Management PepsiCo Alexion Pharmaceuticals
3. Stoke Therapeutics Appoints Julie Anne Smith to its Board of Directors
  
  Explore businesswire.com Jun 4 2020 BoardMoves
  
  ...or to joining Raptor, Ms. Smith served as the Chief Commercial Officer at Enobia Pharmaceuticals (acquired by Alexion Pharmaceuticals, Inc.). Earlier in her career, she held positions of increasing responsibility at Jazz...
  Read Full Article
  
  Comment
  
  Mentions: Bristol-Myers Squibb Alexion Pharmaceuticals Julie Anne Smith
4. François Nader, MD, Joins Moderna's Board of Directors
  
  Explore businesswire.com Dec 10 2019 BoardMoves
  
  ...N), Prevail Therapeutics (NASDAQ: PRVL) and Talaris Therapeutics. He also serves on the Board of Directors of Alexion Pharmaceuticals (NASDAQ: ALXN) and advisor for SVB-Leerink. Dr. Nader is the past Chairman of BioNJ, N...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Leadership Sanofi
5. Is Elon Musk's Clash With the SEC a Big Deal for Tesla Stock? It Doesn't Seem That Way.
  
  Explore entrepreneur.com Feb 27 2019 BoardBlogs
  
  ...g a new 52-week high in the process. Other gains on the Entrepreneur Index™ included Gap Inc. (2.05 percent), Alexion Pharmaceuticals, (2.04 percent), and Capital One Financial, (1.68 percent). It was a relatively quiet ...
  Read Full Article
  
  Comment
  
  Mentions: Twitter Tesla acquisition
6. Ludwig N. Hantson Elected to Hologic Board of Directors
  
  Explore businesswire.com Nov 19 2018 BoardMoves
  
  ...on, who has more than 30 years of experience in the life sciences industry, is the Chief Executive Officer of Alexion Pharmaceuticals, Inc., a publicly-traded global biopharmaceutical company. Before joining Alexion, Dr....
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Alexion Pharmaceuticals Hologic
7. Six CEO Pay Packages That Explain Soaring Executive Compensation
  
  Explore CNBC.com May 25 2018 BoardBlogs
  
  ...ractors who do not appear on the payroll. It's a model popular with other drug companies on the Equilar list. Alexion Pharmaceuticals, Vertex Pharmaceuticals and BioMarin Pharmaceutical also had relatively low pay ratios...
  Read Full Article
  
  Comment
  
  Mentions: Google stake Alexion Pharmaceuticals
8. Alexion Appoints Judith A. Reinsdorf, JD, to its Board of Directors
  
  Explore Digital Journal Feb 5 2018 BoardMoves
  
  ...d executive with a strong background in corporate governance and broad... NEW HAVEN, Conn.--(Business Wire)--Alexion Pharmaceuticals, Inc. (NASDAQ:ALXN) today announced that Judith A. Reinsdorf, J.D., has been appointed...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Alexion Pharmaceuticals Johnson Controls
9. Alexion Pharmaceuticals : Agrees to Work With Hedge Fund Elliott on Filling Board Seat--Update
  
  Explore 4-traders : one website, all markets Jan 3 2018 BoardNews
  
  ...nies including aluminum parts maker Arconic Inc. and Brocade Communication Systems, now part of Broadcom Ltd. Alexion Pharmaceuticals Inc. said Tuesday it will work with hedge fund Elliott Management Corp. on filling an ...
  Read Full Article
  
  Comment
  
  Mentions: Management Hedge Fund Arconic
10. Alexion and Elliott Agree to Collaborate on Identifying a New Board Member
  
  Explore businesswire.com Jan 2 2018 BoardNews
  
  ... CFA, 475-230-3601 Vice President, Investor Relations Catherine Hu, 475-230-3599 Director, Investor Relations Alexion Pharmaceuticals, Inc. Media: Kim Diamond, 475-230-3775 Executive Director, Corporate Communications In...
  Read Full Article
  
  Comment
  
  Mentions: Investor Relations Nasdaq Alexion Pharmaceuticals
11. Alexion Pharmaceuticals, Inc. (NASDAQ: Alxn) Names Francois Nader to Board of Directors
  
  Explore StreetInsider.com Nov 8 2017 BoardMoves
  
  ...Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) today announced that Francois Nader, M.D., has been appointed to the Company's Board of Directors ... ...
  Read Full Article
  
  Comment
  
  Mentions: Nasdaq Alexion Pharmaceuticals François Nader
12. 1-10 of 10

Mentioned In 10 Articles

Categories

BoardProspects Features:

Related Topics